Building Fucoidan/Agarose-Based Hydrogels as a Platform for the Development of Therapeutic Approaches against Diabetes

Current management for diabetes has stimulated the development of versatile 3D-based hydrogels as in vitro platforms for insulin release and as support for the encapsulation of pancreatic cells and islets of Langerhans. This work aimed to create agarose/fucoidan hydrogels to encapsulate pancreatic c...

Full description

Bibliographic Details
Main Authors: Lara L. Reys, Simone S. Silva, Diana Soares da Costa, Luísa C. Rodrigues, Rui L. Reis, Tiago H. Silva
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/28/11/4523
_version_ 1797597012768587776
author Lara L. Reys
Simone S. Silva
Diana Soares da Costa
Luísa C. Rodrigues
Rui L. Reis
Tiago H. Silva
author_facet Lara L. Reys
Simone S. Silva
Diana Soares da Costa
Luísa C. Rodrigues
Rui L. Reis
Tiago H. Silva
author_sort Lara L. Reys
collection DOAJ
description Current management for diabetes has stimulated the development of versatile 3D-based hydrogels as in vitro platforms for insulin release and as support for the encapsulation of pancreatic cells and islets of Langerhans. This work aimed to create agarose/fucoidan hydrogels to encapsulate pancreatic cells as a potential biomaterial for diabetes therapeutics. The hydrogels were produced by combining fucoidan (Fu) and agarose (Aga), marine polysaccharides derived from the cell wall of brown and red seaweeds, respectively, and a thermal gelation process. The agarose/fucoidan (AgaFu) blended hydrogels were obtained by dissolving Aga in 3 or 5 wt % Fu aqueous solutions to obtain different proportions (4:10; 5:10, and 7:10 wt). The rheological tests on hydrogels revealed a non-Newtonian and viscoelastic behavior, while the characterization confirmed the presence of the two polymers in the structure of the hydrogels. In addition, the mechanical behavior showed that increasing Aga concentrations resulted in hydrogels with higher Young’s modulus. Further, the ability of the developed materials to sustain the viability of human pancreatic cells was assessed by encapsulation of the 1.1B4HP cell line for up to 7 days. The biological assessment of the hydrogels revealed that cultured pancreatic beta cells tended to self-organize and form pseudo-islets during the period studied.
first_indexed 2024-03-11T03:00:48Z
format Article
id doaj.art-86b471a9845b474d8df56db9d4efb8ac
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-11T03:00:48Z
publishDate 2023-06-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-86b471a9845b474d8df56db9d4efb8ac2023-11-18T08:17:46ZengMDPI AGMolecules1420-30492023-06-012811452310.3390/molecules28114523Building Fucoidan/Agarose-Based Hydrogels as a Platform for the Development of Therapeutic Approaches against DiabetesLara L. Reys0Simone S. Silva1Diana Soares da Costa2Luísa C. Rodrigues3Rui L. Reis4Tiago H. Silva53B’s Research Group, I3Bs—Research Institute on Biomaterials, Biodegradables and Biomimetics of University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark—Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017 Barco, Guimarães, Portugal3B’s Research Group, I3Bs—Research Institute on Biomaterials, Biodegradables and Biomimetics of University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark—Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017 Barco, Guimarães, Portugal3B’s Research Group, I3Bs—Research Institute on Biomaterials, Biodegradables and Biomimetics of University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark—Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017 Barco, Guimarães, Portugal3B’s Research Group, I3Bs—Research Institute on Biomaterials, Biodegradables and Biomimetics of University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark—Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017 Barco, Guimarães, Portugal3B’s Research Group, I3Bs—Research Institute on Biomaterials, Biodegradables and Biomimetics of University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark—Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017 Barco, Guimarães, Portugal3B’s Research Group, I3Bs—Research Institute on Biomaterials, Biodegradables and Biomimetics of University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark—Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017 Barco, Guimarães, PortugalCurrent management for diabetes has stimulated the development of versatile 3D-based hydrogels as in vitro platforms for insulin release and as support for the encapsulation of pancreatic cells and islets of Langerhans. This work aimed to create agarose/fucoidan hydrogels to encapsulate pancreatic cells as a potential biomaterial for diabetes therapeutics. The hydrogels were produced by combining fucoidan (Fu) and agarose (Aga), marine polysaccharides derived from the cell wall of brown and red seaweeds, respectively, and a thermal gelation process. The agarose/fucoidan (AgaFu) blended hydrogels were obtained by dissolving Aga in 3 or 5 wt % Fu aqueous solutions to obtain different proportions (4:10; 5:10, and 7:10 wt). The rheological tests on hydrogels revealed a non-Newtonian and viscoelastic behavior, while the characterization confirmed the presence of the two polymers in the structure of the hydrogels. In addition, the mechanical behavior showed that increasing Aga concentrations resulted in hydrogels with higher Young’s modulus. Further, the ability of the developed materials to sustain the viability of human pancreatic cells was assessed by encapsulation of the 1.1B4HP cell line for up to 7 days. The biological assessment of the hydrogels revealed that cultured pancreatic beta cells tended to self-organize and form pseudo-islets during the period studied.https://www.mdpi.com/1420-3049/28/11/4523fucoidanagarosehydrogelsdiabetes mellituscell encapsulationpancreatic beta cells
spellingShingle Lara L. Reys
Simone S. Silva
Diana Soares da Costa
Luísa C. Rodrigues
Rui L. Reis
Tiago H. Silva
Building Fucoidan/Agarose-Based Hydrogels as a Platform for the Development of Therapeutic Approaches against Diabetes
Molecules
fucoidan
agarose
hydrogels
diabetes mellitus
cell encapsulation
pancreatic beta cells
title Building Fucoidan/Agarose-Based Hydrogels as a Platform for the Development of Therapeutic Approaches against Diabetes
title_full Building Fucoidan/Agarose-Based Hydrogels as a Platform for the Development of Therapeutic Approaches against Diabetes
title_fullStr Building Fucoidan/Agarose-Based Hydrogels as a Platform for the Development of Therapeutic Approaches against Diabetes
title_full_unstemmed Building Fucoidan/Agarose-Based Hydrogels as a Platform for the Development of Therapeutic Approaches against Diabetes
title_short Building Fucoidan/Agarose-Based Hydrogels as a Platform for the Development of Therapeutic Approaches against Diabetes
title_sort building fucoidan agarose based hydrogels as a platform for the development of therapeutic approaches against diabetes
topic fucoidan
agarose
hydrogels
diabetes mellitus
cell encapsulation
pancreatic beta cells
url https://www.mdpi.com/1420-3049/28/11/4523
work_keys_str_mv AT laralreys buildingfucoidanagarosebasedhydrogelsasaplatformforthedevelopmentoftherapeuticapproachesagainstdiabetes
AT simonessilva buildingfucoidanagarosebasedhydrogelsasaplatformforthedevelopmentoftherapeuticapproachesagainstdiabetes
AT dianasoaresdacosta buildingfucoidanagarosebasedhydrogelsasaplatformforthedevelopmentoftherapeuticapproachesagainstdiabetes
AT luisacrodrigues buildingfucoidanagarosebasedhydrogelsasaplatformforthedevelopmentoftherapeuticapproachesagainstdiabetes
AT ruilreis buildingfucoidanagarosebasedhydrogelsasaplatformforthedevelopmentoftherapeuticapproachesagainstdiabetes
AT tiagohsilva buildingfucoidanagarosebasedhydrogelsasaplatformforthedevelopmentoftherapeuticapproachesagainstdiabetes